A470 Phase II Trial of Mel/Dex + Bortezomib for AL Amyloidosis

C Gasparetto; JA Zonder; R Snyder; H Terebelo; D Benson; N Janakiraman; M Mapara; J Matous; V Sanchorawala; S Lalo; D Monsma; J Abrams

doi:10.1016/S1557-9190(11)70594-7

A470 Phase II Trial of Mel/Dex + Bortezomib for AL Amyloidosis

C Gasparetto
, JA Zonder
, R Snyder
, H Terebelo
, D Benson
, N Janakiraman
, M Mapara
, J Matous
, V Sanchorawala
, S Lalo
, D Monsma
, J Abrams

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Clinical Lymphoma, Myeloma & Leukemia
Volume	9
DOIs	https://doi.org/10.1016/S1557-9190(11)70594-7
State	Published - Feb 1 2009

Disciplines

Medicine and Health Sciences
Oncology

Access to Document

10.1016/S1557-9190(11)70594-7License: Unspecified

Cite this

@article{a007ab11a5304d4c8a230a99974af829,

title = "A470 Phase II Trial of Mel/Dex + Bortezomib for AL Amyloidosis",

author = "C Gasparetto and JA Zonder and R Snyder and H Terebelo and D Benson and N Janakiraman and M Mapara and J Matous and V Sanchorawala and S Lalo and D Monsma and J Abrams",

note = "To read this article in full you will need to make a payment Clinical Studies Including Transplantation This article might include the discussion of investigational and/or unlabeled uses of drugs and/or devices that might not be approved by the FDA. Electronic forwarding or copying is a violation of US and international copyright laws.",

year = "2009",

month = feb,

day = "1",

doi = "10.1016/S1557-9190(11)70594-7",

language = "American English",

volume = "9",

journal = "Clinical Lymphoma, Myeloma \& Leukemia",

}

TY - JOUR

T1 - A470 Phase II Trial of Mel/Dex + Bortezomib for AL Amyloidosis

AU - Gasparetto, C

AU - Zonder, JA

AU - Snyder, R

AU - Terebelo, H

AU - Benson, D

AU - Janakiraman, N

AU - Mapara, M

AU - Matous, J

AU - Sanchorawala, V

AU - Lalo, S

AU - Monsma, D

AU - Abrams, J

N1 - To read this article in full you will need to make a payment Clinical Studies Including Transplantation This article might include the discussion of investigational and/or unlabeled uses of drugs and/or devices that might not be approved by the FDA. Electronic forwarding or copying is a violation of US and international copyright laws.

PY - 2009/2/1

Y1 - 2009/2/1

UR - https://www.clinical-lymphoma-myeloma-leukemia.com/article/S1557-9190(11)70594-7/fulltext

U2 - 10.1016/S1557-9190(11)70594-7

DO - 10.1016/S1557-9190(11)70594-7

M3 - Article

VL - 9

JO - Clinical Lymphoma, Myeloma & Leukemia

JF - Clinical Lymphoma, Myeloma & Leukemia

ER -

A470 Phase II Trial of Mel/Dex + Bortezomib for AL Amyloidosis

Disciplines

Access to Document

Other files and links

Cite this